{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T17:53:05Z","timestamp":1774633985103,"version":"3.50.1"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100007076","name":"Fondazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003981","name":"Agenzia Spaziale Italiana","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003981","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009647","name":"Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009647","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.imlet.2017.08.014","type":"journal-article","created":{"date-parts":[[2017,8,19]],"date-time":"2017-08-19T04:02:54Z","timestamp":1503115374000},"page":"185-193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["NK cells of HIV-1-infected patients with poor CD4+ T-cell reconstitution despite suppressive HAART show reduced IFN-\u03b3 production and high frequency of autoreactive CD56bright cells"],"prefix":"10.1016","volume":"190","author":[{"given":"Erica","family":"Giuliani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lia","family":"Vassena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Di Cesare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Malagnino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Giovanna","family":"Desimio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Andreoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Barnaba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margherita","family":"Doria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.imlet.2017.08.014_bib0005","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1086\/695852","article-title":"The absence of CD4+ T cell count recovery despite receipt of virologically suppressive highly active antiretroviral therapy: clinical risk, immunological gaps, and therapeutic options","volume":"48","author":"Gazzola","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.imlet.2017.08.014_bib0010","doi-asserted-by":"crossref","first-page":"670957","DOI":"10.1155\/2012\/670957","article-title":"Incomplete immune recovery in HIV infection: mechanisms, relevance for clinical care, and possible solutions","volume":"2012","author":"Gaardbo","year":"2012","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.imlet.2017.08.014_bib0015","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1086\/374786","article-title":"T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy","volume":"187","author":"Hunt","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.imlet.2017.08.014_bib0020","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1097\/01.aids.0000247588.69438.fd","article-title":"T-cell homeostasis alteration in HIV-1 infected subjects with low CD4 T-cell count despite undetectable virus load during HAART","volume":"20","author":"Marziali","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.imlet.2017.08.014_bib0025","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1097\/01.aids.0000242819.72839.db","article-title":"Comparative analysis of T-cell turnover and homeostatic parameters in HIV-infected patients with discordant immune-virological responses to HAART","volume":"20","author":"Marchetti","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.imlet.2017.08.014_bib0030","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1097\/QAD.0b013e328339cf40","article-title":"Skewed T-cell maturation and function in HIV-infected patients failing CD4+ recovery upon long-term virologically suppressive HAART","volume":"24","author":"Marchetti","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.imlet.2017.08.014_bib0035","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1097\/QAD.0b013e32833c93ce","article-title":"Immune activation, apoptosis, and Treg activity are associated with persistently reduced CD4+ T-cell counts during antiretroviral therapy","volume":"24","author":"Piconi","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.imlet.2017.08.014_bib0040","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/infdis\/jis630","article-title":"Cell-based measures of viral persistence are associated with immune activation and programmed cell death protein 1 (PD-1)-expressing CD4+ T cells","volume":"208","author":"Hatano","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.imlet.2017.08.014_bib0045","doi-asserted-by":"crossref","first-page":"401","DOI":"10.7326\/0003-4819-133-6-200009190-00007","article-title":"Clinical outcome of patients with HIV-1 infection according to immunologic and virologic response after 6 months of highly active antiretroviral therapy","volume":"133","author":"Grabar","year":"2000","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.imlet.2017.08.014_bib0050","doi-asserted-by":"crossref","first-page":"100","DOI":"10.2174\/157016208783885038","article-title":"J. del Amo, CoRIS-MD Patients' characteristics and clinical implications of suboptimal CD4 T-cell gains after 1year of successful antiretroviral therapy","volume":"6","author":"Gutierrez","year":"2008","journal-title":"Curr. HIV Res."},{"key":"10.1016\/j.imlet.2017.08.014_bib0055","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/QAI.0b013e31816856c5","article-title":"Clinical outcome of HIV-infected antiretroviral-naive patients with discordant immunologic and virologic responses to highly active antiretroviral therapy","volume":"47","author":"Tan","year":"2008","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.imlet.2017.08.014_bib0060","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1097\/QAD.0b013e32835cb747","article-title":"Risk of clinical progression among patients with immunological nonresponse despite virological suppression after combination antiretroviral treatment","volume":"27","author":"Lapadula","year":"2013","journal-title":"AIDS"},{"key":"10.1016\/j.imlet.2017.08.014_bib0065","doi-asserted-by":"crossref","first-page":"e87160","DOI":"10.1371\/journal.pone.0087160","article-title":"Immuno-virological discordance and the risk of non-AIDS and AIDS events in a large observational cohort of HIV-patients in Europe","volume":"9","author":"Zoufaly","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.imlet.2017.08.014_bib0070","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1097\/00002030-200109280-00002","article-title":"Poor CD4T cell restoration after suppression of HIV-1 replication may reflect lower thymic function","volume":"15","author":"Teixeira","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/j.imlet.2017.08.014_bib0075","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1086\/429670","article-title":"Mechanisms involved in the low-level regeneration of CD4+ cells in HIV-1-infected patients receiving highly active antiretroviral therapy who have prolonged undetectable plasma viral loads","volume":"191","author":"Benveniste","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.imlet.2017.08.014_bib0080","doi-asserted-by":"crossref","first-page":"5142","DOI":"10.1182\/blood-2011-01-331306","article-title":"HIV disease progression despite suppression of viral replication is associated with exhaustion of lymphopoiesis","volume":"117","author":"Sauce","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.imlet.2017.08.014_bib0085","doi-asserted-by":"crossref","first-page":"10229","DOI":"10.1128\/JVI.00965-06","article-title":"Naive T-cell depletion related to infection by X4 human immunodeficiency virus type 1 in poor immunological responders to highly active antiretroviral therapy","volume":"80","author":"Delobel","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.imlet.2017.08.014_bib0090","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.clim.2004.12.008","article-title":"Multiparameter evaluation of human thymic function: interpretations and caveats","volume":"115","author":"Harris","year":"2005","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.imlet.2017.08.014_bib0095","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1097\/QAD.0b013e328361a3fe","article-title":"NKp44L expression on CD4+ T cells is associated with impaired immunological recovery in HIV-infected patients under highly active antiretroviral therapy","volume":"27","author":"Sennepin","year":"2013","journal-title":"AIDS"},{"key":"10.1016\/j.imlet.2017.08.014_bib0100","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/ni1582","article-title":"Functions of natural killer cells","volume":"9","author":"Vivier","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imlet.2017.08.014_bib0105","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S1471-4906(01)02060-9","article-title":"The biology of human natural killer-cell subsets","volume":"22","author":"Cooper","year":"2001","journal-title":"Trends Immunol."},{"key":"10.1016\/j.imlet.2017.08.014_bib0110","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.4049\/jimmunol.178.8.4947","article-title":"CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation","volume":"178","author":"Romagnani","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2017.08.014_bib0115","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1182\/blood-2002-08-2568","article-title":"Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation","volume":"101","author":"Shilling","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.imlet.2017.08.014_bib0120","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1084\/jem.20082013","article-title":"IL-15 trans-presentation promotes human NK cell development and differentiation in vivo","volume":"206","author":"Huntington","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imlet.2017.08.014_bib0125","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.it.2010.08.003","article-title":"CD56 negative NK cells: origin, function, and role in chronic viral disease","volume":"31","author":"Bjorkstrom","year":"2010","journal-title":"Trends Immunol."},{"key":"10.1016\/j.imlet.2017.08.014_bib0130","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/nri1711","article-title":"NK cells in HIV infection: paradigm for protection or targets for ambush","volume":"5","author":"Fauci","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.imlet.2017.08.014_bib0135","doi-asserted-by":"crossref","first-page":"8705","DOI":"10.1128\/JVI.02666-08","article-title":"Matrix metalloprotease inhibitors restore impaired NK cell-mediated antibody-dependent cellular cytotoxicity in human immunodeficiency virus type 1 infection","volume":"83","author":"Liu","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.imlet.2017.08.014_bib0140","doi-asserted-by":"crossref","first-page":"11970","DOI":"10.1073\/pnas.1302090110","article-title":"Natural killer cells in HIV controller patients express an activated effector phenotype and do not up-regulate NKp44 on IL-2 stimulation","volume":"110","author":"Marras","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.imlet.2017.08.014_bib0145","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s10072-007-0803-3","article-title":"Expansion of CD56Bright natural killer cells in the peripheral blood of multiple sclerosis patients treated with interferon-beta","volume":"28","author":"Saraste","year":"2007","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.imlet.2017.08.014_bib0150","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jneuroim.2009.08.007","article-title":"Interferon-beta-1a treatment increases CD56bright natural killer cells and CD4+CD25+ Foxp3 expression in subjects with multiple sclerosis","volume":"215","author":"Vandenbark","year":"2009","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.imlet.2017.08.014_bib0155","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1365-2567.2008.02887.x","article-title":"Increased proportion of CD56bright natural killer cells in active and inactive systemic lupus erythematosus","volume":"126","author":"Schepis","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.imlet.2017.08.014_bib0160","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.4049\/jimmunol.170.7.3572","article-title":"Activated, but not resting T cells can be recognized and killed by syngeneic NK cells","volume":"170","author":"Rabinovich","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2017.08.014_bib0165","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1182\/blood-2006-10-052720","article-title":"Antigen-activated human T lymphocytes express cell-surface NKG2D ligands via an ATM\/ATR-dependent mechanism and become susceptible to autologous NK- cell lysis","volume":"110","author":"Cerboni","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.imlet.2017.08.014_bib0170","doi-asserted-by":"crossref","first-page":"e31959","DOI":"10.1371\/journal.pone.0031959","article-title":"Cytotoxicity of CD56(bright) NK cells towards autologous activated CD4+ T cells is mediated through NKG2D, LFA-1 and TRAIL and dampened via CD94\/NKG2A","volume":"7","author":"Nielsen","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.imlet.2017.08.014_bib0175","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1189\/jlb.0606409","article-title":"Control of NK cell functions by CD4+CD25+ regulatory T cells","volume":"81","author":"Ralainirina","year":"2007","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.imlet.2017.08.014_bib0180","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.autrev.2011.05.004","article-title":"Human FoxP3+ regulatory T cells in systemic autoimmune diseases","volume":"10","author":"Miyara","year":"2011","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.imlet.2017.08.014_bib0185","doi-asserted-by":"crossref","first-page":"10981","DOI":"10.1073\/pnas.0504315102","article-title":"NK cytotoxicity against CD4+ T cells during HIV-1 infection: a gp41 peptide induces the expression of an NKp44 ligand","volume":"102","author":"Vieillard","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.imlet.2017.08.014_bib0190","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2172-15-2","article-title":"High CD56 + +CD16- natural killer (NK) cells among suboptimal immune responders after four years of suppressive antiretroviral therapy in an African adult HIV treatment cohort","volume":"15","author":"Bayigga","year":"2014","journal-title":"BMC. Immunol."},{"key":"10.1016\/j.imlet.2017.08.014_bib0195","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.4049\/jimmunol.1200140","article-title":"Peripheral blood NK cells from breast cancer patients are tumor-induced composite subsets","volume":"190","author":"Mamessier","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2017.08.014_bib0200","doi-asserted-by":"crossref","first-page":"316314","DOI":"10.1155\/2011\/316314","article-title":"Expansion of CD16-negative natural killer cells in the peripheral blood of patients with metastatic melanoma","volume":"2011","author":"Holtan","year":"2011","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.imlet.2017.08.014_bib0205","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1080\/00365540600740520","article-title":"A case of HHV-6 associated acute necrotizing encephalopathy with increase of CD56bright NKcells","volume":"38","author":"Kubo","year":"2006","journal-title":"Scand. J. Infect. Dis."},{"key":"10.1016\/j.imlet.2017.08.014_bib0210","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1136\/gut.2007.130963","article-title":"Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure","volume":"57","author":"Golden-Mason","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.imlet.2017.08.014_bib0215","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4049\/jimmunol.172.1.88","article-title":"The IL-12 signature: NK cell terminal CD56+high stage and effector functions","volume":"172","author":"Loza","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2017.08.014_bib0220","doi-asserted-by":"crossref","first-page":"e57336","DOI":"10.1371\/journal.pone.0057336","article-title":"Poor immune reconstitution in HIV-infected patients associates with high percentage of regulatory CD4+ T cells","volume":"8","author":"Horta","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.imlet.2017.08.014_bib0225","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1093\/infdis\/jis230","article-title":"Severe immune dysregulation affects CD4(+)CD25(hi)FoxP3(+) regulatory T cells in HIV-infected patients with low-level CD4 T-cell repopulation despite suppressive highly active antiretroviral therapy","volume":"205","author":"Mendez-Lagares","year":"2012","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.imlet.2017.08.014_bib0230","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1097\/QAD.0000000000000022","article-title":"Immunologic nonresponders and T-regulatory cells in HIV-1 infection","volume":"27","author":"Suy","year":"2013","journal-title":"AIDS"},{"key":"10.1016\/j.imlet.2017.08.014_bib0235","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/QAI.0000000000000173","article-title":"Regulatory T cells in HIV-infected immunological nonresponders are increased in blood but depleted in lymphoid tissue and predict immunological reconstitution","volume":"66","author":"Gaardbo","year":"2014","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.imlet.2017.08.014_bib0240","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/cei.12278","article-title":"Lyon HIV Cohort Study, Association between discordant immunological response to highly active anti-retroviral therapy, regulatory T cell percentage, immune cell activation and very low-level viraemia in HIV-infected patients","volume":"176","author":"Saison","year":"2014","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.imlet.2017.08.014_bib0245","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3389\/fimmu.2013.00215","article-title":"CD4+FOXP3+ regulatory T-Cell subsets in human immunodeficiency virus infection","volume":"4","author":"Simonetta","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imlet.2017.08.014_bib0250","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.clim.2004.04.003","article-title":"CD4 + CD25+ T regulatory cells inhibit cytotoxic activity of T CD8+ and NK lymphocytes in the direct cell-to-cell interaction","volume":"112","author":"Trzonkowski","year":"2004","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.imlet.2017.08.014_bib0255","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1002\/eji.200526069","article-title":"Activation of human NK cells by plasmacytoid dendritic cells and its modulation by CD4+ T helper cells and CD4+ CD25hi T regulatory cells","volume":"35","author":"Romagnani","year":"2005","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.imlet.2017.08.014_bib0260","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1084\/jem.20051511","article-title":"CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner","volume":"202","author":"Ghiringhelli","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imlet.2017.08.014_bib0265","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1084\/jem.20122571","article-title":"IL-2-dependent adaptive control of NK cell homeostasis","volume":"210","author":"Gasteiger","year":"2013","journal-title":"J. Exp. Med."}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247817303097?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247817303097?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,15]],"date-time":"2021-05-15T10:16:02Z","timestamp":1621073762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247817303097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":53,"alternative-id":["S0165247817303097"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2017.08.014","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NK cells of HIV-1-infected patients with poor CD4+ T-cell reconstitution despite suppressive HAART show reduced IFN-\u03b3 production and high frequency of autoreactive CD56bright cells","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2017.08.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}